The 12 core Investing Club portfolio stocks that we identified at our Annual Meeting in February are the 12 we still stand by. On Thursday, during our September Monthly Meeting, a member asked Jim Cramer whether he would change any of the core holdings, which are Apple , Amazon , Costco , Danaher , Eaton , GE Healthcare , Linde , Eli Lilly , Meta Platforms , Microsoft , Nvidia , and TJX Companies . Jim said no. “I just want to add one,” he added. “I said Wells Fargo would be good down here.” Wells Fargo Why we own it We bought Wells Fargo as a turnaround story under CEO Charlie Scharf. He’s been making progress cleaning up the bank’s act and fixing its previously bloated cost structure after a series of misdeeds before his tenure. Scharf has also been working to get the Fed’s $1.95 trillion asset cap lifted and to boost Wells Fargo’s fee-generating revenue streams. Competitors : Bank of America and Citigroup Initiated : Jan. 8, 2021 The Club owns 2,440 shares of Wells Fargo , which gets our buy-equivalent 1 rating and a $62 per share price target. Wells touched $62.55, its highest level since January 2018, back in May of this year. The stock has dropped some 13% since then to around $54. It’s up 9.5% year to date compared to the S & P 500 ‘s more than 17% gain. Jim said Wells Fargo is doing great. “I think that CEO Charlie Scharf has a winning formula for when rates go down,” he added. “Call me a buyer not a seller.” GE Healthcare “I know the softest is GE Healthcare ,” Jim said, though he wants to sit in the stock for a while to see if it can find its footing. “I don’t like to add good money to bad. GE Healthcare at $86 is not something I would add to.” Why we own it GE Healthcare is the global leader in medical imaging, diagnostics, and digital solutions in health care. Its split from General Electric in 2023 enabled the now-standalone company to invest more aggressively in R & D, leading to new product innovations, especially in artificial intelligence. The combination of new, higher-priced products along with the optimization of its business post-split creates an underappreciated margin expansion story. The rollout of new Alzheimer’s disease therapies is another longer-term tailwind. Competitors : Philips and Siemens Initiated : May, 17, 2023 We own 1,000 shares of GEHC. Reflecting Jim’s view of not buying here, the stock has our wait-for-a-pullback 2 rating and a $92 price target. GEHC hit an all-time high of $94.50 in March. The stock has dropped 8% since. Year to date, it has increased more than 12%. The investment thesis is still there for GEHC to benefit from the radiology needed for patients and would-be patients of an emerging class of Alzheimer’s drugs, one of which is made by Lilly. Fed interest rate cuts can also help hospitals finance the MRI and CT scan machines that GE Healthcare is known for. (See here for a full list of the stocks in Jim Cramer’s Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
Read the full article here